HBC logo

Hofseth BioCare ASA Stock Price

OB:HBC Community·NOK 575.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

HBC Share Price Performance

NOK 0
-2.10 (-100.00%)
NOK 0
-2.10 (-100.00%)
Price NOK 0

HBC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk and slightly overvalued.

4 Risks
0 Rewards

Hofseth BioCare ASA Key Details

NOK 256.3m

Revenue

NOK 177.6m

Cost of Revenue

NOK 78.7m

Gross Profit

NOK 213.6m

Other Expenses

-NOK 134.9m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 08, 2026
-0.33
30.70%
-52.62%
-337.2%
View Full Analysis

About HBC

Founded
2000
Employees
81
CEO
Jon Odegard
WebsiteView website
www.hofsethbiocare.com

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a salmon oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.

Recent HBC News & Updates

Recent updates

No updates